Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Body Dysmorphic Disorders | 7 | 2023 | 209 | 1.150 |
Why?
|
Happiness | 2 | 2019 | 172 | 0.820 |
Why?
|
Smoking Cessation | 12 | 2021 | 2045 | 0.730 |
Why?
|
Psychotherapy | 5 | 2023 | 1565 | 0.560 |
Why?
|
Tobacco Use Disorder | 5 | 2021 | 696 | 0.520 |
Why?
|
Quercus | 1 | 2013 | 3 | 0.510 |
Why?
|
Betula | 1 | 2013 | 7 | 0.510 |
Why?
|
Acer | 1 | 2013 | 4 | 0.510 |
Why?
|
Grief | 4 | 2020 | 242 | 0.500 |
Why?
|
Plant Leaves | 1 | 2013 | 137 | 0.480 |
Why?
|
Self Care | 1 | 2019 | 804 | 0.470 |
Why?
|
Substance-Related Disorders | 2 | 2019 | 4192 | 0.460 |
Why?
|
Bereavement | 3 | 2020 | 255 | 0.420 |
Why?
|
Yoga | 2 | 2022 | 228 | 0.350 |
Why?
|
Implosive Therapy | 2 | 2018 | 113 | 0.320 |
Why?
|
Tourette Syndrome | 2 | 2022 | 391 | 0.320 |
Why?
|
Anxiety Disorders | 5 | 2022 | 2589 | 0.310 |
Why?
|
Nicotinic Agonists | 4 | 2017 | 272 | 0.300 |
Why?
|
Verbal Learning | 2 | 2019 | 477 | 0.280 |
Why?
|
Social Perception | 2 | 2019 | 420 | 0.260 |
Why?
|
Tic Disorders | 2 | 2022 | 120 | 0.260 |
Why?
|
Facial Expression | 2 | 2019 | 502 | 0.260 |
Why?
|
Quality of Life | 5 | 2023 | 11760 | 0.250 |
Why?
|
Tics | 1 | 2022 | 66 | 0.220 |
Why?
|
Veterans | 3 | 2020 | 2337 | 0.220 |
Why?
|
Military Personnel | 3 | 2020 | 1068 | 0.220 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2020 | 45 | 0.190 |
Why?
|
Smoking | 6 | 2021 | 8948 | 0.190 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2020 | 77 | 0.190 |
Why?
|
Guilt | 1 | 2020 | 96 | 0.180 |
Why?
|
Behavior Therapy | 3 | 2022 | 871 | 0.180 |
Why?
|
Combat Disorders | 2 | 2020 | 302 | 0.180 |
Why?
|
Schizophrenia | 5 | 2017 | 6753 | 0.170 |
Why?
|
Cycloserine | 1 | 2018 | 115 | 0.170 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2020 | 4081 | 0.160 |
Why?
|
Depressive Disorder, Major | 3 | 2020 | 4473 | 0.160 |
Why?
|
Smiling | 1 | 2017 | 71 | 0.160 |
Why?
|
Anger | 1 | 2019 | 406 | 0.150 |
Why?
|
September 11 Terrorist Attacks | 1 | 2017 | 107 | 0.150 |
Why?
|
Quinoxalines | 2 | 2014 | 301 | 0.130 |
Why?
|
Psychotherapy, Group | 1 | 2018 | 407 | 0.130 |
Why?
|
Personality | 1 | 2018 | 527 | 0.130 |
Why?
|
Benzazepines | 2 | 2014 | 329 | 0.130 |
Why?
|
Mecamylamine | 1 | 2013 | 29 | 0.130 |
Why?
|
Bipolar Disorder | 3 | 2017 | 5060 | 0.130 |
Why?
|
Alcoholics Anonymous | 1 | 2014 | 74 | 0.120 |
Why?
|
Trees | 1 | 2013 | 56 | 0.120 |
Why?
|
Motivation | 3 | 2019 | 1903 | 0.120 |
Why?
|
Nicotinic Antagonists | 1 | 2013 | 95 | 0.120 |
Why?
|
Male | 33 | 2023 | 351380 | 0.120 |
Why?
|
Comorbidity | 7 | 2022 | 10451 | 0.120 |
Why?
|
Adult | 26 | 2023 | 212451 | 0.120 |
Why?
|
Marijuana Smoking | 1 | 2016 | 252 | 0.110 |
Why?
|
Middle Aged | 23 | 2023 | 215041 | 0.110 |
Why?
|
Female | 33 | 2023 | 377909 | 0.110 |
Why?
|
Feasibility Studies | 2 | 2019 | 4921 | 0.110 |
Why?
|
Treatment Outcome | 16 | 2023 | 62348 | 0.110 |
Why?
|
Remote Sensing Technology | 1 | 2013 | 95 | 0.110 |
Why?
|
Telomere | 1 | 2018 | 829 | 0.110 |
Why?
|
Soil | 1 | 2012 | 89 | 0.110 |
Why?
|
Self Concept | 1 | 2018 | 1029 | 0.110 |
Why?
|
Pattern Recognition, Visual | 1 | 2017 | 831 | 0.110 |
Why?
|
Plants | 1 | 2012 | 302 | 0.100 |
Why?
|
Humans | 43 | 2023 | 717237 | 0.100 |
Why?
|
Cannabis | 1 | 2016 | 334 | 0.100 |
Why?
|
Tuberculosis | 1 | 2023 | 1829 | 0.100 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2342 | 0.100 |
Why?
|
Temperature | 2 | 2013 | 2161 | 0.100 |
Why?
|
Schizophrenic Psychology | 2 | 2017 | 1683 | 0.100 |
Why?
|
Mental Recall | 1 | 2016 | 1205 | 0.090 |
Why?
|
Memory, Short-Term | 1 | 2016 | 940 | 0.090 |
Why?
|
Young Adult | 13 | 2022 | 56247 | 0.090 |
Why?
|
Self Efficacy | 3 | 2019 | 629 | 0.090 |
Why?
|
Memory Disorders | 1 | 2016 | 1144 | 0.090 |
Why?
|
Suicide | 1 | 2020 | 1572 | 0.090 |
Why?
|
Ecosystem | 1 | 2012 | 427 | 0.080 |
Why?
|
Seasons | 1 | 2013 | 1431 | 0.080 |
Why?
|
Mental Disorders | 2 | 2018 | 6431 | 0.080 |
Why?
|
Alcohol Drinking | 2 | 2017 | 3885 | 0.080 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3600 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5452 | 0.080 |
Why?
|
Afghan Campaign 2001- | 2 | 2020 | 297 | 0.080 |
Why?
|
HIV Infections | 2 | 2023 | 15672 | 0.080 |
Why?
|
Depression | 4 | 2020 | 7280 | 0.070 |
Why?
|
Internet | 1 | 2019 | 3082 | 0.070 |
Why?
|
Emotions | 1 | 2017 | 2451 | 0.070 |
Why?
|
Weight Gain | 1 | 2016 | 2209 | 0.070 |
Why?
|
Decision Making | 1 | 2019 | 3848 | 0.070 |
Why?
|
Social Support | 3 | 2020 | 2120 | 0.070 |
Why?
|
Self Report | 3 | 2021 | 3431 | 0.070 |
Why?
|
Alcoholism | 1 | 2014 | 1861 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2018 | 16017 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2019 | 5728 | 0.060 |
Why?
|
Adolescent | 9 | 2022 | 85139 | 0.050 |
Why?
|
Massachusetts | 1 | 2013 | 8749 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2018 | 8923 | 0.050 |
Why?
|
Sleep | 3 | 2020 | 4222 | 0.050 |
Why?
|
Signal Detection, Psychological | 1 | 2019 | 88 | 0.050 |
Why?
|
Uganda | 1 | 2023 | 1110 | 0.040 |
Why?
|
Sertraline | 1 | 2020 | 215 | 0.040 |
Why?
|
Compulsive Behavior | 1 | 2019 | 104 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1571 | 0.040 |
Why?
|
Affective Symptoms | 1 | 2020 | 409 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 5883 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2018 | 11910 | 0.040 |
Why?
|
Anxiety | 2 | 2022 | 3922 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2021 | 1594 | 0.040 |
Why?
|
Prospective Studies | 5 | 2021 | 51275 | 0.040 |
Why?
|
Citalopram | 1 | 2020 | 408 | 0.040 |
Why?
|
Harm Reduction | 1 | 2017 | 115 | 0.040 |
Why?
|
Cognition | 1 | 2013 | 6109 | 0.040 |
Why?
|
Stereotyping | 1 | 2018 | 239 | 0.040 |
Why?
|
Communicable Disease Control | 1 | 2023 | 812 | 0.040 |
Why?
|
HIV | 1 | 2023 | 1517 | 0.030 |
Why?
|
Health Behavior | 2 | 2017 | 2616 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2017 | 426 | 0.030 |
Why?
|
Attention | 2 | 2017 | 2414 | 0.030 |
Why?
|
Saliva | 1 | 2018 | 786 | 0.030 |
Why?
|
Aged | 7 | 2023 | 162856 | 0.030 |
Why?
|
Negotiating | 1 | 2014 | 129 | 0.030 |
Why?
|
Cues | 1 | 2018 | 860 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2020 | 614 | 0.030 |
Why?
|
Serotonin Uptake Inhibitors | 1 | 2021 | 1428 | 0.030 |
Why?
|
Plant Physiological Phenomena | 1 | 2012 | 16 | 0.030 |
Why?
|
Droughts | 1 | 2012 | 25 | 0.030 |
Why?
|
Rain | 1 | 2012 | 57 | 0.030 |
Why?
|
Rural Population | 1 | 2023 | 2168 | 0.030 |
Why?
|
Psychometrics | 1 | 2021 | 2971 | 0.030 |
Why?
|
Plant Roots | 1 | 2012 | 107 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 621 | 0.030 |
Why?
|
Polysomnography | 1 | 2018 | 1749 | 0.030 |
Why?
|
Wakefulness | 1 | 2018 | 1178 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 932 | 0.030 |
Why?
|
Probability | 1 | 2016 | 2489 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 23409 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2018 | 1734 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1114 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 14381 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39302 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2391 | 0.020 |
Why?
|
Outpatients | 1 | 2017 | 1370 | 0.020 |
Why?
|
Leukocytes | 1 | 2018 | 2103 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2013 | 815 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2004 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18798 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5981 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 2620 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13612 | 0.020 |
Why?
|
Reaction Time | 1 | 2013 | 2138 | 0.020 |
Why?
|
Hippocampus | 1 | 2019 | 3660 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6197 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8066 | 0.020 |
Why?
|
Water | 1 | 2012 | 1339 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 14896 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2021 | 4162 | 0.020 |
Why?
|
United States | 3 | 2020 | 67798 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1338 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12923 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2018 | 3817 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2012 | 1428 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5213 | 0.020 |
Why?
|
Pandemics | 1 | 2023 | 7292 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9047 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2014 | 2777 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 2017 | 2848 | 0.010 |
Why?
|
Child | 2 | 2022 | 74387 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3956 | 0.010 |
Why?
|
Telemedicine | 1 | 2017 | 2624 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 6929 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9577 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3070 | 0.010 |
Why?
|
Hypertension | 1 | 2016 | 8286 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 41095 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12247 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 34502 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 72614 | 0.010 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_